GLENMARK PHARM. NIGERIA LTD. was formed with the vision of providing simple, effective and holistic solutions to people looking for a quality pharmaceuticals in Lagos, Nigeria.    GLENMARK PHARM. NIGERIA LTD. is run by a core team of highly qualified professionals with rich experience in Healthcare systems and Pharmacy Benefits Program's. Our team of trained counselors and experts help customers choose the right product/services.   Our customers can easily order medicines from the convenience of their home or office or even on the go. We provide timely home delivery of drugs on cash on delivery.    We offer Pharmacy Drugs, OTC medicines, Health Nutrition, Healthcare Devices, Makeup and Beauty items, Personal needs & Childcare products. We only deliver 100% genuine and original products    We are passionate about on-time delivery and ready availability of maximum range of products.   GLENMARK PHARM. NIGERIA LTD. is your one-stop pharmacy to buy medicines.

GETZ PHARMA LTD is an international research-driven, branded generic pharmaceutical company specializing in the formulation, development, manufacturing and marketing of a wide range of quality, affordable medicines. We manufacture and market brands trusted by healthcare professionals around the world. Our products are manufactured at our cGMP-compliant facility and tested at our Quality Control Laboratory which is pre-qualified by the World Health Organization (WHO).   Getz Pharma's mission is to develop, produce and market safe, effective and quality medicines and healthcare products that will improve the health and quality of life of men, women and children. Getz Pharma is an international research-driven, branded generic pharmaceutical company specializing in the formulation development, manufacturing, testing and marketing of a wide range of quality, affordable medicines. We manufacture and market brands trusted by healthcare professionals around the world. We are the only company whose manufacturing facility, in Pakistan, is approved by the World Health Organization, Geneva (WHO). Our Quality Control Laboratory is also the first and only in Pakistan to have been Pre-qualified and approved by WHO. Additionally, our manufacturing facility is the first and only, in Pakistan, certified and approved by a member country of the Pharmaceutical Inspection Co-operation Scheme (PIC/S), which comprises more than 50 participating authorities, including US FDA and European Medicines Agency, among others. Getz Pharma currently operates in more than 25 countries in South Asia, Central Asia, South East Asia, the Middle East and Africa. IMS rates Getz Pharma as the fastest growing pharmaceutical company within most countries where it operates.  

Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia focused on providing acute care, specialist-orientated, multi-disciplinary hospital services and related service offerings. We place science at the heart of our care process by striving to provide evidence-based care of the highest standard. The group currently operates 48 private hospitals (excluding four day clinics) throughout South Africa and three hospitals in Namibia with more than 8 200 beds in total. Mediclinic Southern Africa is a wholly owned subsidiary of the international private healthcare group Mediclinic International PLC, listed on the LSE (London Stock Exchange) with a secondary listing on the JSE (Johannesburg Stock Exchange) and the NSX (Namibian Stock Exchange). Mediclinic International currently has three operating divisions - Mediclinic Southern Africa which operates 51 private hospitals and four day clinics throughout South Africa and Namibia; Hirslanden operates 17 private acute care facilities and four clinics in Switzerland with more than 1 800 inpatient beds and Mediclinic Middle East which operates six hospitals and 22 clinics with more than 700 inpatient beds in the United Arab Emirates. The group also holds a minority interest of 29.9% in Spire Healthcare Group PLC, a leading private hospital group in the United Kingdom and also listed on the LSE.

Dana Pharmaceuticals Limited commenced manufacturing of intravenous fluids in 1996. The factory has been expanded with the setting up of a formulation plant for the manufacture of a wide range of pharmaceutical formulations. With our motto “a Commitment to Healthcare” in mind and one of the best technologies in hand, we are devoted to the production of quality and genuine products that are offered at the most affordable prices nationwide. Our pharmaceutical products include: Amaxin Amebanil Danacillin Danaclox Danacyclin Dana CPM Danacid Ferrodan Paradana Quimal Backed by nationwide network of branches together with a large fleet of distribution vans, we have established ourselves as a major player in the trade. Some of our products – like Paradana and Ferrodan, have become brand leaders in their segment. Over the years, Dana Pharmaceuticals has obtained NAFDAC’s seal of approval on more than 27 products including Formulations and Antibiotics. From its maiden advent in Pharmaceuticals manufacturing in the mid-80′s, the Group diversified into various Commodities trading, Plastic manufacturing, Bottled water manufacturing, Automobiles assembly, and Steel manufacturing.  In continuing with the Group’s vision of adding value to the economy and creating a sustainable industrial base, the successful commissioning of a Plastics Plant for household products in the year 2000 was followed by the expansion of its Pharmaceutical Formulation Capacity and Range and the setting up of a new Drinking Water Bottling Plant in 2003. Dana Group also acquired Steel Rolling Mill in Katsina to produce debars and wire rods, in 2006, which was turned around with significant capital investment and backward integration, regenerating employment in the state. Alongside these enterprises, after successfully bringing Kia Motors to the forefront in Nigeria with nationwide distribution and service centres, in line with the Federal governments Auto Policy the Group commissioned an auto assembly plant in 2015 to assemble a range of models under the stringent requirements of Kia Motors’ global standards. Dana Group has a conglomerate presence with businesses that cover a wide spectrum. With its resources, reach and marketing acumen, the Group will lead the field for a very long time to come. The turn of the century has fulfilled its vision of becoming a large conglomerate with interests in diverse fields of operations, be it manufacturing, trading or service.  The Group’s diversification into the Automobile Sector lends further credence to its capability and multi-faceted operations including after-sales service and customer care. Sound financials and exemplary business vision have made the group a leader in every area of operation. Its latest and most exciting venture has been its entry in the Aviation industry with the launch of Dana Air at the end of 2008, serving domestic routes with daily scheduled flights and charter operations, and now known for it’s award-winning service and standards. The contribution of Dana Group to the National Economy has been immense and beyond doubt. Apart from making many people gainfully employed either directly or indirectly, it has dutifully established itself as a socially responsible organization. Among others, Dana Group is sponsoring Sri Sai Vandana Foundation (SSVF), a registered charity since 1995 in Nigeria. SSVF conducts frequent and regular humanitarian service activities and participates in programmes committed to alleviating the underprivileged in Nigeria.

Bond Chemist Limited was initially set up as a retail outlet for Pharmaceutical Products in 1976 by our visionary leader Sir Chief Adebowale Omotosho which later metamorphosed to Bond Chemical Industries Limited in 1988. The then management team of the company later instituted a producer structure for the company, and this we know today by name Bond Chemical Industries Limited. The factory of Bond Chemical Limited situated in Awe, Oyo State of Nigeria and was officially commissioned on March 18th, 1988 and the Corporate Head Office located in Lagos. Bond has expanded more than five times the size it was at inception. This expansion is in terms of structure, equipment and workforce alongside qualitative products. Our aim is to be a leader in the business of using science and equipment to improve quality of life, offering wide range of high quality and excellent pharmaceutical products that meet our numerous customers’ needs, achieving tangible returns and reasonable growth on Shareholders’ investment, through a virile, well motivated work-force and operating a good corporate entity with high standard of security, ethics, Good Manufacturing Practice (GMP) and sensitivity to human health.